We've found
9,144
archived clinical trials in
Ocular
We've found
9,144
archived clinical trials in
Ocular
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Updated: 3/22/2017
A Randomized, Multicenter, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Prevalence Study of Adrenal Suppression After Corticosteroids During Chemotherapy
Updated: 3/23/2017
A Prevalence Study of Adrenal Suppression After Adjuvant Corticosteroid Administration During Gynecologic Cancer Chemotherapy
Status: Enrolling
Updated: 3/23/2017
Prevalence Study of Adrenal Suppression After Corticosteroids During Chemotherapy
Updated: 3/23/2017
A Prevalence Study of Adrenal Suppression After Adjuvant Corticosteroid Administration During Gynecologic Cancer Chemotherapy
Status: Enrolling
Updated: 3/23/2017
Click here to add this to my saved trials
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Updated: 4/6/2017
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Status: Enrolling
Updated: 4/6/2017
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Updated: 4/6/2017
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Status: Enrolling
Updated: 4/6/2017
Click here to add this to my saved trials
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Updated: 4/6/2017
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Status: Enrolling
Updated: 4/6/2017
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Updated: 4/6/2017
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Status: Enrolling
Updated: 4/6/2017
Click here to add this to my saved trials
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Updated: 4/6/2017
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Status: Enrolling
Updated: 4/6/2017
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Updated: 4/6/2017
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Status: Enrolling
Updated: 4/6/2017
Click here to add this to my saved trials
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Updated: 4/6/2017
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Status: Enrolling
Updated: 4/6/2017
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Updated: 4/6/2017
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Status: Enrolling
Updated: 4/6/2017
Click here to add this to my saved trials
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Updated: 4/6/2017
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Status: Enrolling
Updated: 4/6/2017
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Updated: 4/6/2017
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Status: Enrolling
Updated: 4/6/2017
Click here to add this to my saved trials
An Evaluation of the Ability to Train Established Glaucoma Patients Who Have Difficulty in Drop Instillation
Updated: 4/11/2017
A Prospective Evaluation of the Effect of Training on Eye Drop Administration in Glaucoma Subjects Who Have Difficulties Properly Instilling Eye Drops
Status: Enrolling
Updated: 4/11/2017
An Evaluation of the Ability to Train Established Glaucoma Patients Who Have Difficulty in Drop Instillation
Updated: 4/11/2017
A Prospective Evaluation of the Effect of Training on Eye Drop Administration in Glaucoma Subjects Who Have Difficulties Properly Instilling Eye Drops
Status: Enrolling
Updated: 4/11/2017
Click here to add this to my saved trials
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
Updated: 4/12/2017
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting IOL Model TFNT00
Status: Enrolling
Updated: 4/12/2017
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
Updated: 4/12/2017
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting IOL Model TFNT00
Status: Enrolling
Updated: 4/12/2017
Click here to add this to my saved trials
Clinical Assessment of a Customized Free-form Progressive Addition Lens Spectacle
Updated: 4/17/2017
Clinical Assessment of a Customized Free-form Progressive Addition Lens Spectacle
Status: Enrolling
Updated: 4/17/2017
Clinical Assessment of a Customized Free-form Progressive Addition Lens Spectacle
Updated: 4/17/2017
Clinical Assessment of a Customized Free-form Progressive Addition Lens Spectacle
Status: Enrolling
Updated: 4/17/2017
Click here to add this to my saved trials
Blood and Saliva Sample Collection for AREDS 2
Updated: 4/19/2017
Blood and Saliva Sample Collection and Submission to the Age-Related Eye Disease Study 2 (AREDS2) Genetic Repository
Status: Enrolling
Updated: 4/19/2017
Blood and Saliva Sample Collection for AREDS 2
Updated: 4/19/2017
Blood and Saliva Sample Collection and Submission to the Age-Related Eye Disease Study 2 (AREDS2) Genetic Repository
Status: Enrolling
Updated: 4/19/2017
Click here to add this to my saved trials
Growth Hormone for Osteoporosis Pseudoglioma Syndrome
Updated: 4/20/2017
Trial of Growth Hormone for Osteoporosis Pseudoglioma Syndrome
Status: Enrolling
Updated: 4/20/2017
Growth Hormone for Osteoporosis Pseudoglioma Syndrome
Updated: 4/20/2017
Trial of Growth Hormone for Osteoporosis Pseudoglioma Syndrome
Status: Enrolling
Updated: 4/20/2017
Click here to add this to my saved trials
Tear Dynamics After Restasis Treatment in Dry Eye Patients
Updated: 4/24/2017
Tear Dynamics After Restasis Treatment in Dry Eye Patients Phase II Clinical Trial and Phase IIb 6-month Follow-up After Discontinuation of Study Treatment
Status: Enrolling
Updated: 4/24/2017
Tear Dynamics After Restasis Treatment in Dry Eye Patients
Updated: 4/24/2017
Tear Dynamics After Restasis Treatment in Dry Eye Patients Phase II Clinical Trial and Phase IIb 6-month Follow-up After Discontinuation of Study Treatment
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.
Updated: 4/25/2017
Safety and Efficacy of Topical Loteprednol Etabonate 0.5%, Versus Prednisolone Acetate 1%, for the Treatment of Intraocular Inflammation Following Surgery for Childhood Cataract
Status: Enrolling
Updated: 4/25/2017
Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.
Updated: 4/25/2017
Safety and Efficacy of Topical Loteprednol Etabonate 0.5%, Versus Prednisolone Acetate 1%, for the Treatment of Intraocular Inflammation Following Surgery for Childhood Cataract
Status: Enrolling
Updated: 4/25/2017
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Updated: 5/1/2017
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Click here to add this to my saved trials
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
Updated: 5/2/2017
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
Status: Enrolling
Updated: 5/2/2017
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
Updated: 5/2/2017
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
Status: Enrolling
Updated: 5/2/2017
Click here to add this to my saved trials
Evaluation of Ocular Comfort With ISTA Tears vs Systane
Updated: 5/8/2017
Evaluation of Ocular Comfort With ISTA Tears vs Systane
Status: Enrolling
Updated: 5/8/2017
Evaluation of Ocular Comfort With ISTA Tears vs Systane
Updated: 5/8/2017
Evaluation of Ocular Comfort With ISTA Tears vs Systane
Status: Enrolling
Updated: 5/8/2017
Click here to add this to my saved trials
A Proposed Intervention to Decrease Resident-Performed Cataract Surgery Cancellation
Updated: 5/8/2017
A Proposed Intervention to Decrease Resident-Performed Cataract Surgery Cancellation
Status: Enrolling
Updated: 5/8/2017
A Proposed Intervention to Decrease Resident-Performed Cataract Surgery Cancellation
Updated: 5/8/2017
A Proposed Intervention to Decrease Resident-Performed Cataract Surgery Cancellation
Status: Enrolling
Updated: 5/8/2017
Click here to add this to my saved trials
SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy
Updated: 5/9/2017
A Phase 1b, Randomized, Uncontrolled, Single-masked, Safety, Tolerability, and Pharmacokinetic Study of Multiple Doses of Three Different Concentrations (0.1%, 1.0%, 5.0%) of SAR 1118 Ophthalmic Solution in Human Subjects Undergoing Elective Pars Plana Vitrectomy (PPV)
Status: Enrolling
Updated: 5/9/2017
SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy
Updated: 5/9/2017
A Phase 1b, Randomized, Uncontrolled, Single-masked, Safety, Tolerability, and Pharmacokinetic Study of Multiple Doses of Three Different Concentrations (0.1%, 1.0%, 5.0%) of SAR 1118 Ophthalmic Solution in Human Subjects Undergoing Elective Pars Plana Vitrectomy (PPV)
Status: Enrolling
Updated: 5/9/2017
Click here to add this to my saved trials
Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study
Updated: 5/11/2017
Evaluation of New Self-Test Visual Function Assessment System for Diabetic Retinopathy
Status: Enrolling
Updated: 5/11/2017
Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study
Updated: 5/11/2017
Evaluation of New Self-Test Visual Function Assessment System for Diabetic Retinopathy
Status: Enrolling
Updated: 5/11/2017
Click here to add this to my saved trials
Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study
Updated: 5/11/2017
Evaluation of New Self-Test Visual Function Assessment System for Diabetic Retinopathy
Status: Enrolling
Updated: 5/11/2017
Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study
Updated: 5/11/2017
Evaluation of New Self-Test Visual Function Assessment System for Diabetic Retinopathy
Status: Enrolling
Updated: 5/11/2017
Click here to add this to my saved trials
Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye
Updated: 6/8/2017
A Randomized, Single-Center, Comparative Study of Rohto Dry-Aid® and Systane® Ultra in the Management of Tear Film Stability and Visual Function in Patients With Dry Eye
Status: Enrolling
Updated: 6/8/2017
Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye
Updated: 6/8/2017
A Randomized, Single-Center, Comparative Study of Rohto Dry-Aid® and Systane® Ultra in the Management of Tear Film Stability and Visual Function in Patients With Dry Eye
Status: Enrolling
Updated: 6/8/2017
Click here to add this to my saved trials
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Updated: 6/19/2017
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Status: Enrolling
Updated: 6/19/2017
Click here to add this to my saved trials